+

WO2009011112A1 - プロスタグランジンe1を含む安定な脂肪乳剤 - Google Patents

プロスタグランジンe1を含む安定な脂肪乳剤 Download PDF

Info

Publication number
WO2009011112A1
WO2009011112A1 PCT/JP2008/001865 JP2008001865W WO2009011112A1 WO 2009011112 A1 WO2009011112 A1 WO 2009011112A1 JP 2008001865 W JP2008001865 W JP 2008001865W WO 2009011112 A1 WO2009011112 A1 WO 2009011112A1
Authority
WO
WIPO (PCT)
Prior art keywords
fat emulsion
emulsion containing
prostaglandin
containing prostaglandin
stable fat
Prior art date
Application number
PCT/JP2008/001865
Other languages
English (en)
French (fr)
Inventor
Takayuki Fukuyama
Kazuhiko Ozaki
Kenichi Hirai
Original Assignee
Mitsubishi Tanabe Pharma Corporation
Taisho Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Tanabe Pharma Corporation, Taisho Pharmaceutical Co., Ltd. filed Critical Mitsubishi Tanabe Pharma Corporation
Priority to CN200880024114A priority Critical patent/CN101743010A/zh
Priority to KR1020157002118A priority patent/KR101588558B1/ko
Priority to JP2009523535A priority patent/JP5890599B2/ja
Publication of WO2009011112A1 publication Critical patent/WO2009011112A1/ja

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

 プロスタグランジンE1活性を有する化合物を含有する脂肪乳剤であって、ガラス製容器に密封された後に加熱滅菌されており、5°Cで16ヶ月間保存後にプロスタグランジンE1活性の残存量が保存開始時の65%以上100%以下である脂肪乳剤。
PCT/JP2008/001865 2007-07-13 2008-07-11 プロスタグランジンe1を含む安定な脂肪乳剤 WO2009011112A1 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN200880024114A CN101743010A (zh) 2007-07-13 2008-07-11 含有前列腺素e1的稳定的脂肪乳剂
KR1020157002118A KR101588558B1 (ko) 2007-07-13 2008-07-11 프로스타글란딘 e1을 포함하는 안정한 지방 유제
JP2009523535A JP5890599B2 (ja) 2007-07-13 2008-07-11 プロスタグランジンe1を含む安定な脂肪乳剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-184358 2007-07-13
JP2007184358 2007-07-13

Publications (1)

Publication Number Publication Date
WO2009011112A1 true WO2009011112A1 (ja) 2009-01-22

Family

ID=40259458

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/001865 WO2009011112A1 (ja) 2007-07-13 2008-07-11 プロスタグランジンe1を含む安定な脂肪乳剤

Country Status (6)

Country Link
JP (2) JP5890599B2 (ja)
KR (2) KR101588558B1 (ja)
CN (1) CN101743010A (ja)
MY (1) MY158088A (ja)
TW (1) TW200920379A (ja)
WO (1) WO2009011112A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013006811A (ja) * 2011-06-27 2013-01-10 Fujifilm Corp 容器詰製剤
WO2019230964A1 (ja) * 2018-05-31 2019-12-05 富士フイルム株式会社 容器詰水中油型乳化組成物

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102038639B (zh) * 2010-12-24 2012-05-02 海南碧凯药业有限公司 一种前列地尔注射制剂
CN102198095A (zh) * 2011-05-03 2011-09-28 北京中海康医药科技发展有限公司 一种依前列醇脂肪乳及其制备方法
CN107519132A (zh) * 2017-08-29 2017-12-29 辅必成(上海)医药科技有限公司 一种前列地尔的纳米脂肪乳剂

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02175630A (ja) * 1988-12-27 1990-07-06 Matsumoto Seiyaku Kogyo Kk 医療用ガラス製品内表面の金属酸化物処理によるアルカリ等の溶出防止法
JPH06263481A (ja) * 1992-11-18 1994-09-20 Koa Glass Kk アルカリ等の溶出防止機能を有するガラス製品及びその製造方法
JPH0769897A (ja) * 1993-09-01 1995-03-14 Green Cross Corp:The 血中トリグリセリド低下作用剤
JPH09235230A (ja) * 1995-12-29 1997-09-09 Hisamitsu Pharmaceut Co Inc イオントフォレーシス用製剤
WO1999009992A1 (fr) * 1997-08-27 1999-03-04 Yoshitomi Pharmaceutical Industries, Ltd. Promoteurs de neovascularisation
JP2006188474A (ja) * 2005-01-07 2006-07-20 Nichi-Iko Pharmaceutical Co Ltd 安定性に優れた脂肪乳剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07206472A (ja) * 1994-01-12 1995-08-08 Nippon Electric Glass Co Ltd 医薬用ホウケイ酸ガラス
JPH08104620A (ja) * 1994-10-05 1996-04-23 Green Cross Corp:The 薬物含有脂肪乳剤
JPH08175998A (ja) * 1994-12-19 1996-07-09 Takada Seiyaku Kk シリコート容器を用いた凍結乾燥製剤
JP2001328612A (ja) * 2000-05-22 2001-11-27 Daiwa Tokushu Glass Kk 低アルカリガラス容器及びその製造方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02175630A (ja) * 1988-12-27 1990-07-06 Matsumoto Seiyaku Kogyo Kk 医療用ガラス製品内表面の金属酸化物処理によるアルカリ等の溶出防止法
JPH06263481A (ja) * 1992-11-18 1994-09-20 Koa Glass Kk アルカリ等の溶出防止機能を有するガラス製品及びその製造方法
JPH0769897A (ja) * 1993-09-01 1995-03-14 Green Cross Corp:The 血中トリグリセリド低下作用剤
JPH09235230A (ja) * 1995-12-29 1997-09-09 Hisamitsu Pharmaceut Co Inc イオントフォレーシス用製剤
WO1999009992A1 (fr) * 1997-08-27 1999-03-04 Yoshitomi Pharmaceutical Industries, Ltd. Promoteurs de neovascularisation
JP2006188474A (ja) * 2005-01-07 2006-07-20 Nichi-Iko Pharmaceutical Co Ltd 安定性に優れた脂肪乳剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
TEAGARDEN D.L. ET AL.: "Dehydration Kinetics of Prostaglandin E1 in a lipid Emulsion", PHARMACEUTICAL RESEARCH, vol. 6, no. 3, 1989, pages 210 - 215, XP000942335 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013006811A (ja) * 2011-06-27 2013-01-10 Fujifilm Corp 容器詰製剤
WO2019230964A1 (ja) * 2018-05-31 2019-12-05 富士フイルム株式会社 容器詰水中油型乳化組成物

Also Published As

Publication number Publication date
KR101588558B1 (ko) 2016-01-28
CN101743010A (zh) 2010-06-16
JP5965944B2 (ja) 2016-08-10
JPWO2009011112A1 (ja) 2010-09-16
KR20150017775A (ko) 2015-02-17
JP2014224131A (ja) 2014-12-04
TW200920379A (en) 2009-05-16
KR20100053541A (ko) 2010-05-20
MY158088A (en) 2016-08-30
JP5890599B2 (ja) 2016-03-22

Similar Documents

Publication Publication Date Title
WO2009091717A3 (en) Smokeless tobacco
MX362807B (es) Formulacion estabilizada de pemetrexed.
WO2009011112A1 (ja) プロスタグランジンe1を含む安定な脂肪乳剤
MX2011012122A (es) Derivados de tiofeno.
WO2006078659A3 (en) Stable prostaglandin-containing compositions
WO2007144770A8 (en) Bacterium
MY148723A (en) Use of pinolenic acid for the treatment of obesity
WO2011159840A3 (en) Phenylthioacetate compounds, compositions and methods of use
WO2010135530A3 (en) Compounds, compositions and methods for modulating uric acid levels
EA200801859A1 (ru) Неводная композиция стабильного витамина "c", способ ее приготовления и применения
WO2008136393A1 (ja) ラクタム化合物の結晶形およびその製造方法
NZ606366A (en) Stabilization of fsh
WO2009060952A1 (ja) 新規製剤
WO2008025819A3 (en) Formulations of acetylsalicylic acid or its derivatives in soft capsules, exhibiting high stability
WO2018005844A8 (en) PERFUME COMPOSITIONS AND METHODS OF USING THE SAME
PE20151426A1 (es) Solucion para preservar conductos vasculares
MX356093B (es) Un empaque que contiene un condón.
WO2010025859A3 (de) Stabilisierung von zellen durch ionische flüssigkeiten
MX2009007265A (es) Sales, composiciones liquidas acuosas que cotienen sales de acido s-(+)-abscisico y metodos para su preparacion.
WO2008099835A1 (ja) Peg充填硬質カプセル剤のバンドシール
WO2010090765A3 (en) Intrathecal baclofen pharmaceutical dosage forms with fewer degradation products
WO2005102248A3 (en) Silicone vesicles containing actives
WO2012019689A3 (de) Verwendung von hydroxypyridonen oder deren salzen zur stabilisierung von wasserstoffperoxid oder wasserstoffperoxid freisetzenden substanzen
MY161065A (en) Flavor improving materials
WO2006056695A8 (fr) Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200880024114.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08776824

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 12010500027

Country of ref document: PH

ENP Entry into the national phase

Ref document number: 2009523535

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20107002368

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 763/CHENP/2010

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: PI 20095677

Country of ref document: MY

122 Ep: pct application non-entry in european phase

Ref document number: 08776824

Country of ref document: EP

Kind code of ref document: A1

点击 这是indexloc提供的php浏览器服务,不要输入任何密码和下载